Stock information – GB0009252882
The Company has confirmed its name has changed from GlaxoSmithKline plc to GSK plc. The Company announced the decision to change its name to GSK plc on 27 April 2022 together with its first quarter 2022 results. This change has now taken effect. The London Stock Exchange and the New York Stock Exchange will reflect the change of name in due course. Shareholders should note that their shareholdings will be unaffected by the change of name.
If you hold the stock with Pilling & Co you do not have to take any action; we will update your account on your behalf. If you have any queries please contact the team on caisa@Pilling.co.uk